Market Price

80.66 

0.58 0.7%

as of May 14 '21

52 Week Range:

52.97 83.45


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 13.12
14.12
14.88
15.82
16.77
17.83
18.23
19.60
19.64
19.74
22.15
growth rate 7.6% 5.4% 6.3% 6.0% 6.3% 2.2% 7.5% 0.2% 0.5% 12.2%
Earnings BIT 502.04
569.31
604.19
664.69
715.14
768.90
817.47
675.09
693.47
732.97
546.20
growth rate 13.4% 6.1% 10.0% 7.6% 7.5% 6.3% -17.4% 2.7% 5.7% -25.5%
Avg.PE 17.61
16.23
18.62
23.20
26.32
27.94
28.82
19.99
23.43
20.67
21.96
growth rate -7.8% 14.7% 24.6% 13.5% 6.2% 3.2% -30.6% 17.2% -11.8% 6.2%
ROA 7.77
7.92
7.70
7.88
7.92
7.58
7.66
5.59
6.57
8.88
5.41
growth rate 1.9% -2.8% 2.3% 0.5% -4.3% 1.1% -27.0% 17.5% 35.2% -39.1%
ROE 14.25
15.18
15.38
15.99
16.65
16.82
17.85
14.50
18.57
23.32
12.73
growth rate 6.5% 1.3% 4.0% 4.1% 1.0% 6.1% -18.8% 28.1% 25.6% -45.4%
ROIC 12.84
13.19
13.29
13.78
13.89
13.49
13.50
10.08
12.35
16.18
10.29
growth rate 2.7% 0.8% 3.7% 0.8% -2.9% 0.1% -25.3% 22.5% 31.0% -36.4%
Cur. Ratio 1.86
1.79
1.84
1.83
1.64
1.50
1.45
1.45
1.30
1.58
1.66
growth rate -3.8% 2.8% -0.5% -10.4% -8.5% -3.3% 0.0% -10.3% 21.5% 5.1%
Quick Ratio 0.89
0.81
0.77
0.80
0.68
0.61
0.57
0.59
0.52
0.66
0.81
growth rate -9.0% -4.9% 3.9% -15.0% -10.3% -6.6% 3.5% -11.9% 26.9% 22.7%
Leverage 1.89
1.95
2.04
2.02
2.18
2.26
2.41
2.78
2.87
2.39
2.32
growth rate 3.2% 4.6% -1.0% 7.9% 3.7% 6.6% 15.4% 3.2% -16.7% -2.9%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 885.80
943.22
1,079.24
1,119.08
1,127.52
1,229.82
1,254.14
1,522.81
1,168.78
1,246.25
1,424.79
growth rate 6.5% 14.4% 3.7% 0.8% 9.1% 2.0% 21.4% -23.3% 6.6% 14.3%
Acct.Payable 1,193.81
1,427.55
1,515.71
861.00
1,005.80
1,007.25
1,153.01
785.76
880.27
1,005.66
growth rate 19.6% 6.2% -43.2% 16.8% 0.1% 14.5% -31.9% 12.0% 14.2%
Cur.Assets 2,169.30
2,272.51
2,704.38
2,834.67
2,913.17
3,231.10
3,342.78
4,086.02
4,175.22
3,226.50
3,791.42
growth rate 4.8% 19.0% 4.8% 2.8% 10.9% 3.5% 22.2% 2.2% -22.7% 17.5%
Total Assets 4,547.50
4,740.14
5,334.00
5,624.64
6,138.81
6,504.74
6,760.40
7,864.00
8,500.53
7,151.10
7,772.53
growth rate 4.2% 12.5% 5.5% 9.1% 6.0% 3.9% 16.3% 8.1% -15.9% 8.7%
Cash 150.30
147.28
122.08
188.62
89.47
72.09
62.38
174.66
56.89
106.10
421.19
growth rate -2.0% -17.1% 54.5% -52.6% -19.4% -13.5% 180.0% -67.4% 86.5% 297.0%
Inventory 870.20
947.85
1,203.51
1,250.40
1,327.80
1,509.96
1,665.75
1,933.80
1,415.51
1,428.80
1,512.50
growth rate 8.9% 27.0% 3.9% 6.2% 13.7% 10.3% 16.1% -26.8% 0.9% 5.9%
Cur.Liabilities 1,168.10
1,271.64
1,472.71
1,550.66
1,780.11
2,147.00
2,320.65
2,828.98
3,218.83
2,038.37
2,283.10
growth rate 8.9% 15.8% 5.3% 14.8% 20.6% 8.1% 21.9% 13.8% -36.7% 12.0%
Liabilities 2,135.80
1,905.87
2,285.24
2,341.90
2,757.84
3,075.73
3,351.96
4,207.45
4,646.58
3,233.71
3,460.45
growth rate -10.8% 19.9% 2.5% 17.8% 11.5% 9.0% 25.5% 10.4% -30.4% 7.0%
LT Debt 395.30
363.52
488.12
450.23
542.78
463.75
715.46
902.66
977.38
619.25
512.23
growth rate -8.0% 34.3% -7.8% 20.6% -14.6% 54.3% 26.2% 8.3% -36.6% -17.3%
Equity 2,411.60
2,432.22
2,613.59
2,785.20
2,813.59
2,884.26
2,793.07
2,811.50
2,961.33
2,998.04
3,348.17
growth rate 0.9% 7.5% 6.6% 1.0% 2.5% -3.2% 0.7% 5.3% 1.2% 11.7%
Common Shares 187.00
185.00
180.00
175.00
171.00
168.00
164.00
158.00
154.00
149.00
143.00
growth rate -1.1% -2.7% -2.8% -2.3% -1.8% -2.4% -3.7% -2.5% -3.3% -4.0%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 39.00
45.18
51.24
60.22
82.12
71.68
70.18
62.40
71.28
76.22
48.83
growth rate 15.8% 13.4% 17.5% 36.4% -12.7% -2.1% -11.1% 14.2% 6.9% -35.9%
Cash Dividends 159.30
10.06
21.28
19.22
24.99
33.30
32.35
29.13
-17.52
169.30
growth rate -93.7% 111.7% -9.7% 30.0% 33.3% -2.9% -9.9% -100.0% 100.0%
Cash From OA 395.50
554.63
408.10
664.18
592.50
615.50
642.58
545.52
684.71
654.09
598.91
growth rate 40.2% -26.4% 62.8% -10.8% 3.9% 4.4% -15.1% 25.5% -4.5% -8.4%
FCF per Share 1.88
2.33
1.99
3.02
2.97
2.89
3.54
2.91
3.50
3.75
3.30
growth rate 23.9% -14.6% 51.8% -1.7% -2.7% 22.5% -17.8% 20.3% 7.1% -12.0%
Sale Purchase of Stock -335.68
-247.88
-274.50
31.49
14.87
11.40
5.27
growth rate 0.0% 0.0% 100.0% -52.8% -23.3% -53.8%
FCF 350.00
509.00
357.00
604.00
510.00
515.00
545.00
464.00
594.00
578.00
550.00
growth rate 45.4% -29.9% 69.2% -15.6% 1.0% 5.8% -14.9% 28.0% -2.7% -4.8%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 7,526.80
8,530.24
8,939.97
9,560.65
10,371.39
10,629.72
11,571.67
8,883.44
9,417.60
9,985.80
10,119.14
growth rate 13.3% 4.8% 6.9% 8.5% 2.5% 8.9% -23.2% 6.0% 6.0% 1.3%
Op.Income 521.10
367.66
388.08
431.55
715.14
768.90
817.47
675.09
693.47
732.97
546.20
growth rate -29.5% 5.6% 11.2% 65.7% 7.5% 6.3% -17.4% 2.7% 5.7% -25.5%
IBT 502.00
569.31
604.19
664.69
721.05
734.82
774.35
627.45
557.87
884.98
513.81
growth rate 13.4% 6.1% 10.0% 8.5% 1.9% 5.4% -19.0% -11.1% 58.6% -41.9%
Net Income 325.80
367.66
388.08
431.55
466.08
479.06
506.78
406.30
535.88
694.73
403.79
growth rate 12.9% 5.6% 11.2% 8.0% 2.8% 5.8% -19.8% 31.9% 29.6% -41.9%
EPS 1.75
1.99
2.16
2.46
2.72
2.85
3.10
2.57
3.49
4.65
2.82
growth rate 13.7% 8.5% 13.9% 10.6% 4.8% 8.8% -17.1% 35.8% 33.2% -39.4%
Gross Profit 2,170.90
2,418.06
2,507.51
2,656.01
2,911.32
3,006.95
3,226.47
2,746.66
2,910.75
3,090.89
2,814.34
growth rate 11.4% 3.7% 5.9% 9.6% 3.3% 7.3% -14.9% 6.0% 6.2% -9.0%

Quarterly Statements

Item Name Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Earnings BIT 178.65
8.50
194.66
164.38
growth rate -95.2% 2,189.9% -15.6%
Balance Sheet Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Acct.Receivable 1,198.74
1,101.20
1,407.68
1,424.79
growth rate -8.1% 27.8% 1.2%
Acct.Payable 780.85
734.96
1,006.96
1,005.66
growth rate -5.9% 37.0% -0.1%
Cur.Assets 3,619.11
3,409.21
3,869.25
3,791.42
growth rate -5.8% 13.5% -2.0%
Total Assets 7,519.20
7,318.13
7,809.90
7,772.53
growth rate -2.7% 6.7% -0.5%
Cash 617.37
296.11
533.50
421.19
144.54
growth rate -52.0% 80.2% -21.1% -65.7%
Inventory 1,328.41
1,406.72
1,463.43
1,512.50
growth rate 5.9% 4.0% 3.4%
Cur.Liabilities 2,205.83
2,307.24
2,603.81
2,283.10
2,122.77
growth rate 4.6% 12.9% -12.3% -7.0%
Liabilities 3,641.28
3,417.36
3,722.93
3,460.45
3,330.29
growth rate -6.2% 8.9% -7.1% -3.8%
LT Debt 861.85
512.08
511.59
512.23
growth rate -40.6% -0.1% 0.1%
Equity 2,974.58
2,991.09
3,155.27
3,348.17
3,358.17
growth rate 0.6% 5.5% 6.1% 0.3%
Common Shares 1.42
1.42
1.43
1.43
growth rate 0.0% 0.1% 0.0%
Cash Flow Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Capital Expenditures 23.01
7.58
7.21
11.03
growth rate -67.1% -4.9% 53.0%
Cash Dividends 2.96
growth rate
Cash From OA 90.48
-90.75
249.33
349.85
growth rate -100.0% 100.0% 40.3%
Sale Purchase of Stock
growth rate
FCF 67.47
-98.33
242.12
338.82
growth rate -100.0% 100.0% 39.9%
Income Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Sales 2,428.87
1,684.40
2,840.15
3,165.73
growth rate -30.7% 68.6% 11.5%
Op.Income 178.65
8.50
194.66
164.38
growth rate -95.2% 2,189.9% -15.6%
IBT 171.76
-14.80
180.82
176.04
growth rate -100.0% 100.0% -2.6%
Net Income 130.26
-10.80
141.70
142.63
growth rate -100.0% 100.0% 0.7%
EPS
growth rate
Gross Profit 746.04
454.29
754.30
859.71
growth rate -39.1% 66.0% 14.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (22.13)

YOY Growth Grade:

D (35.29)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 28.63 26.27 19.25
EPS / Growth 7.0% 3.07 16.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 4.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.7% 5.9% 5.9%
Future PE 9.48 19.87 19.87
Future EPS 4.88 5.43 5.43
Value Price
MOS %
11.43
-85.8%
26.64
-67.0%
26.64
-67.0%
MOS Price 5.72 13.32 13.32
IRT 16.92 15.76 15.76

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.